281 related articles for article (PubMed ID: 26462717)
1. Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.
McKeown SR; Hatfield P; Prestwich RJ; Shaffer RE; Taylor RE
Br J Radiol; 2015; 88(1056):20150405. PubMed ID: 26462717
[TBL] [Abstract][Full Text] [Related]
2. The risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtual case.
Arruda GV; Weber RRDS; Bruno AC; Pavoni JF
Int J Radiat Biol; 2021; 97(2):120-125. PubMed ID: 33164596
[TBL] [Abstract][Full Text] [Related]
3. Cancer risks from medical radiation.
Ron E
Health Phys; 2003 Jul; 85(1):47-59. PubMed ID: 12852471
[TBL] [Abstract][Full Text] [Related]
4. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
[TBL] [Abstract][Full Text] [Related]
5. Are radiation-induced cavernomas clinically relevant findings? Results from long-term follow-up with brain magnetic resonance imaging of childhood cancer survivors.
Becker L; Gebauer J; Küchler J; Staackmann C; Schacht H; Lauten M; Jensen-Kondering U; Schramm P; Langer T; Neumann A
Radiol Oncol; 2021 Aug; 55(3):274-283. PubMed ID: 34384013
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease.
Mattsson A; Rudén BI; Hall P; Wilking N; Rutqvist LE
J Natl Cancer Inst; 1993 Oct; 85(20):1679-85. PubMed ID: 8411245
[TBL] [Abstract][Full Text] [Related]
7. The long-term side effects of radiation therapy for benign brain tumors in adults.
al-Mefty O; Kersh JE; Routh A; Smith RR
J Neurosurg; 1990 Oct; 73(4):502-12. PubMed ID: 2204689
[TBL] [Abstract][Full Text] [Related]
8. [Very late effects of radiotherapy - limiting factor of current radiotherapy techniques].
Kubeš J; Vítek P; Dědečková K; Ondrová B
Klin Onkol; 2014; 27(3):161-5. PubMed ID: 24918273
[TBL] [Abstract][Full Text] [Related]
9. Risks of secondary malignancies with heterotopic bone radiation therapy for patients younger than 40 years.
Cadieux CL; DesRosiers C; McMullen K
Med Dosim; 2016; 41(3):212-5. PubMed ID: 27156238
[TBL] [Abstract][Full Text] [Related]
10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer risk and radiation dose among women treated for breast cancer.
Inskip PD; Stovall M; Flannery JT
J Natl Cancer Inst; 1994 Jul; 86(13):983-8. PubMed ID: 8007020
[TBL] [Abstract][Full Text] [Related]
12. [The role of external beam radiation therapy in the adjuvant treatment of pigmented villonodular synovitis].
Heyd R; Seegenschmiedt MH; Micke O
Z Orthop Unfall; 2011 Dec; 149(6):677-82. PubMed ID: 21271510
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the treatment of metastatic extradural spinal cord compression in adults.
George R; Jeba J; Ramkumar G; Chacko AG; Tharyan P
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006716. PubMed ID: 26337716
[TBL] [Abstract][Full Text] [Related]
14. Lung Cancer and Heart Disease Risks Associated With Low-Dose Pulmonary Radiotherapy to COVID-19 Patients With Different Background Risks.
Shuryak I; Kachnic LA; Brenner DJ
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):233-239. PubMed ID: 33930480
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.
Seegenschmiedt MH; Keilholz L; Martus P; Goldmann A; Wölfel R; Henning F; Sauer R
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):161-71. PubMed ID: 9300751
[TBL] [Abstract][Full Text] [Related]
17. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
[TBL] [Abstract][Full Text] [Related]
18. Outcome following radiation treatment for high-risk pigmented villonodular synovitis.
O'Sullivan B; Cummings B; Catton C; Bell R; Davis A; Fornasier V; Goldberg R
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):777-86. PubMed ID: 7790264
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk after radiotherapy for benign diseases.
Mazonakis M; Damilakis J
Phys Med; 2017 Oct; 42():285-291. PubMed ID: 28189418
[TBL] [Abstract][Full Text] [Related]
20. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy.
Little MP; de Vathaire F; Shamsaldin A; Oberlin O; Campbell S; Grimaud E; Chavaudra J; Haylock RG; Muirhead CR
Int J Cancer; 1998 Oct; 78(3):269-75. PubMed ID: 9766556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
